NCT04698577 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Döpfner M, Breuer D, Wille N, Erhart M, Ravens-Sieberer U; BELLA study group
How often do children meet ICD-10/DSM-IV criteria of attention deficit-/hyperactivity disorder and hyperkinetic disorder? Parent-based prevalence rates in a national sample--results of the BELLA study. Eur Child Adolesc Psychiatry. 2008 Dec;17 Suppl 1:59-70. doi: 10.1007/s00787-008-1007-y.
DuPaul GJ, Gormley MJ, Laracy SD
School-based interventions for elementary school students with ADHD. Child Adolesc Psychiatr Clin N Am. 2014 Oct;23(4):687-97. doi: 10.1016/j.chc.2014.05.003. Epub 2014 Aug 1. Review.
Gonthier C, Aubry A, Bourdin B
Measuring working memory capacity in children using adaptive tasks: Example validation of an adaptive complex span. Behav Res Methods. 2018 Jun;50(3):910-921. doi: 10.3758/s13428-017-0916-4.
Tang YY, Posner MI
Attention training and attention state training. Trends Cogn Sci. 2009 May;13(5):222-7. doi: 10.1016/j.tics.2009.01.009. Epub 2009 Apr 16. Review.

Evaluation of a School-Based Attention Training Programme for Improving Sustained Attention: A Cluster Randomised Pilot Study

Clinical trial NCT04698577 - References